REFERENCES
- Whitley RJ. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. Recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 1998; 158: 957–69.
- Wohl D, Galvin S, Gibbs S, et al. Characteristics of hos-pitalized HIV-infected patients following the availability of HAART. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, IL USA, January 31-February 4, 1999. Abstract 694.
- Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Ann Intern Med 1997; 126: 264–74.
- Lalezari JP, Kuperrmann BD. Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis. J AIDS Hum Retrovirol 1997; 14 (Suppl. 1): S27-S31.
- Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR. Lack of reactivation of cytomegalovirus retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to Highly Active Antiretroviral Therapy. J Infect Dis 1998; 177: 1182–7.